|
March 31, 2006 Categories: Uncategorized Posted by admin
Guidant Corp. won’t sell its stock of Xience V drug-coated stents because some of the products failed to meet the company’s manufacturing standards, the medical device maker said Wednesday.
Full news
|
|
